Guide: Navigating PCR Billing Challenges in MolDx Jurisdictions
00:00 1X Laboratories performing polymerase chain reaction (PCR)-based diagnostic testing continue to face significant billing and reimbursement challenges, particularly in regions covered by the Molecular Diagnostic Services Program (MolDx). As labs operating... Case Study: Using Billing Data to Bolster Lab Contract Negotiations
Overview A leading laboratory client was initially offered a reimbursement rate of 100% Medicare for their commercial policies. Given that commercial payors typically reimburse significantly higher than Medicare rates, accepting this offer would have left substantial...
The Cost of Cybersecurity Failures in Healthcare: Lessons from the Ascension Breach
The healthcare industry continues to face an increasing number of cybersecurity threats, and the fallout from these breaches can extend far beyond immediate downtime. The Ascension cyberattack in May 2024 serves as a stark reminder of just how vulnerable healthcare... 3 Things to Know When Billing for Genetic and Molecular Testing
As labs throughout the country continue to explore new revenue streams in the face of seemingly endless annual cuts from CMS and commercial payers, many are adding genetic testing and molecular diagnostics to their test menus. However, due to a patchwork of regional... 